Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
829
NCT04774237
Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 24, 2021
Completion: Oct 19, 2021
NCT05135286
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Phase: Phase 3
Start: Mar 15, 2022
Completion: Mar 13, 2025
NCT05270863
Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia
Start: Mar 30, 2022
Completion: Apr 10, 2023